Preclinical efficacy and immunogenicity assessment to show that a chimeric Plasmodium falciparum UB05-09 antigen could be a Malaria Vaccine Candidate.
about
Preclinical efficacy and immunogenicity assessment to show that a chimeric Plasmodium falciparum UB05-09 antigen could be a Malaria Vaccine Candidate.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Preclinical efficacy and immun ...... e a Malaria Vaccine Candidate.
@en
Preclinical efficacy and immun ...... e a Malaria Vaccine Candidate.
@nl
type
label
Preclinical efficacy and immun ...... e a Malaria Vaccine Candidate.
@en
Preclinical efficacy and immun ...... e a Malaria Vaccine Candidate.
@nl
prefLabel
Preclinical efficacy and immun ...... e a Malaria Vaccine Candidate.
@en
Preclinical efficacy and immun ...... e a Malaria Vaccine Candidate.
@nl
P2093
P2860
P356
P1433
P1476
Preclinical efficacy and immun ...... e a Malaria Vaccine Candidate.
@en
P2093
S M Ghogomu
V P K Titanji
P2860
P356
10.1111/PIM.12514
P50
P577
2018-01-25T00:00:00Z